Does DOXAZOSIN Cause Bladder transitional cell carcinoma? 22 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Bladder transitional cell carcinoma have been filed in association with DOXAZOSIN (Doxazosin). This represents 0.5% of all adverse event reports for DOXAZOSIN.
22
Reports of Bladder transitional cell carcinoma with DOXAZOSIN
0.5%
of all DOXAZOSIN reports
0
Deaths
22
Hospitalizations
How Dangerous Is Bladder transitional cell carcinoma From DOXAZOSIN?
Of the 22 reports, 22 (100.0%) required hospitalization.
Is Bladder transitional cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXAZOSIN. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does DOXAZOSIN Cause?
Asthma (413)
Dyspnoea (393)
Hypotension (385)
Drug ineffective (367)
Productive cough (350)
Syncope (343)
Dizziness (341)
Wheezing (328)
Condition aggravated (325)
Thrombosis (274)
What Other Drugs Cause Bladder transitional cell carcinoma?
PIOGLITAZONE (398)
ADALIMUMAB (96)
METHOTREXATE (95)
RITUXIMAB (74)
TOCILIZUMAB (68)
INFLIXIMAB (63)
SULFASALAZINE (55)
HYDROXYCHLOROQUINE (50)
PREDNISONE (48)
LENALIDOMIDE (42)
Which DOXAZOSIN Alternatives Have Lower Bladder transitional cell carcinoma Risk?
DOXAZOSIN vs DOXAZOSIN\DOXAZOSIN
DOXAZOSIN vs DOXEPIN
DOXAZOSIN vs DOXERCALCIFEROL
DOXAZOSIN vs DOXIFLURIDINE
DOXAZOSIN vs DOXORUBICIN